[HTML][HTML] Paradoxes in advance care planning: the complex relationship of oncology patients, their physicians, and advance medical directives
LA Dow, RK Matsuyama, V Ramakrishnan… - Journal of Clinical …, 2010 - ncbi.nlm.nih.gov
Purpose Many seriously ill patients with cancer do not discuss prognosis or advance
directives (ADs), which may lead to inappropriate and/or unwanted aggressive care at the …
directives (ADs), which may lead to inappropriate and/or unwanted aggressive care at the …
Giving honest information to patients with advanced cancer maintains hope
TJ Smith, LA Dow, J Khatcheressian, LJ Lyckholm - Oncology, 2010 - search.proquest.com
There was no change in responses to the Herth Hope Index after the intervention (see
Figure 1). In most cases the responses were completely unchanged. For this 12-point scale …
Figure 1). In most cases the responses were completely unchanged. For this 12-point scale …
[HTML][HTML] A pilot trial of decision aids to give truthful prognostic and treatment information to chemotherapy patients with advanced cancer
TJ Smith, LA Dow, EA Virago… - The journal of …, 2011 - ncbi.nlm.nih.gov
Most cancer patients do not have an explicit discussion about prognosis and treatment
despite documented adverse outcomes. Few decision aids have been developed to assist …
despite documented adverse outcomes. Few decision aids have been developed to assist …
A randomized, placebo controlled trial of oral zinc for chemotherapy-related taste and smell disorders
L Lyckholm, SP Heddinger, G Parker… - Journal of pain & …, 2012 - Taylor & Francis
Abnormalities in taste and smell are commonly reported in patients receiving chemotherapy
and may hinder appetite, dietary intake, nutritional well-being, and quality of life. Oral zinc …
and may hinder appetite, dietary intake, nutritional well-being, and quality of life. Oral zinc …
Immune checkpoint inhibitor use near the end of life is associated with poor performance status, lower hospice enrollment, and dying in the hospital
C Glisch, Y Hagiwara… - American Journal of …, 2020 - journals.sagepub.com
Background: Immune checkpoint inhibitors have changed the landscape of cancer care by
increasing progression-free and overall survival in some patients with cancer. We evaluated …
increasing progression-free and overall survival in some patients with cancer. We evaluated …
[HTML][HTML] Severe lactic acidosis in a patient with B-cell lymphoma: a case report and review of the literature
FH Chan, D Carl, LJ Lyckholm - Case Reports in Medicine, 2009 - hindawi.com
Lactic acidosis is commonly observed in clinical situations such as shock and sepsis, as a
result of tissue hypoperfusion and hypoxia. Lymphoma and leukemia are among other …
result of tissue hypoperfusion and hypoxia. Lymphoma and leukemia are among other …
Immune checkpoint inhibitor use near the end of life: a single-center retrospective study
C Glisch, S Saeidzadeh, T Snyders… - Journal of palliative …, 2020 - liebertpub.com
Background: Immune checkpoint inhibitors (ICIs) have revolutionized treatment for many
patients with advanced cancer. Little is known about ICI use near the end of life. Objective …
patients with advanced cancer. Little is known about ICI use near the end of life. Objective …
The end-of-life experience for a cohort of patients with pulmonary arterial hypertension
DC Grinnan, KM Swetz, J Pinson… - Journal of palliative …, 2012 - liebertpub.com
Introduction: Pulmonary arterial hypertension (PAH) is a progressive and ultimately fatal
disease of the pulmonary circulation. There has never been an investigation of the end-of …
disease of the pulmonary circulation. There has never been an investigation of the end-of …
'Futile care': what to do when your patient insists on chemotherapy that likely won't help
J Khatcheressian, SB Harrington, LJ Lyckholm… - Oncology, 2008 - go.gale.com
While there is no generally accepted medical definition of" futile care," many factors may
play a role in the delivery of chemotherapy to patients who are unlikely to benefit. In this …
play a role in the delivery of chemotherapy to patients who are unlikely to benefit. In this …
Association of hemophagocytic lymphohistiocytosis and programmed death 1 checkpoint inhibitors
B Laderian, K Koehn, C Holman, L Lyckholm… - Journal of thoracic …, 2019 - jto.org
To the Editor: A 49-year-old man with history of schizoaffective disorder and psoriasis
received pembrolizumab for metastatic thymic carcinoma. Before starting immune …
received pembrolizumab for metastatic thymic carcinoma. Before starting immune …